FOSB and B-cell chronic lymphocytic leukemia: By characterizing the unique features of both AP‐1‐expressing, core‐associated CLL cells and the novel, core‐associated BMSC subset, our data offer promising approaches for the development of therapeutic strategies that disrupt these critical interactions in CLL.